Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | BAX | Q07812 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4400918 | 1.00 | MAPT (0.64) | MAPTATMSMN1; SMN2RAD52ADRA2A | |
| SCHEMBL16908299 | 1.00 | MAPT (0.64) | MAPTATMSMN1; SMN2RAD52ADRA2A | |
| SCHEMBL15553304 | 0.98 | MAPT (0.61) | MAPTATMSMN1; SMN2RAD52ADRA2A | |
| SCHEMBL14034485 | 0.98 | MAPT (0.61) | MAPTATMSMN1; SMN2RAD52ADRA2A | |
| SCHEMBL10696876 | 0.98 | MAPT (0.61) | MAPTATMSMN1; SMN2RAD52ADRA2A | |
| SCHEMBL21757993 | 0.98 | MAPT (0.61) | MAPTATMSMN1; SMN2RAD52ADRA2A | |
| SCHEMBL9493787 | 0.92 | MAPT (0.67) | MAPTATMSMN1; SMN2RAD52ADRA2A | |
| SCHEMBL11438133 | 0.88 | SMN1; SMN2 (0.60) | MAPTATMSMN1; SMN2RAD52MEN1 | |
| SCHEMBL9059747 | 0.87 | MAPT (0.54) | MAPTATMSMN1; SMN2RAD52ADRA2A | |
| SCHEMBL151400 | 0.86 | SMN1; SMN2 (0.58) | MAPTATMSMN1; SMN2RAD52MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 268 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115646137-B | Organic amine desulfurizing agent capable of effectively reducing foaming problem | 北京北大先锋科技股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4663277-A1 | AMINE COMPOSITION FOR CARBON DIOXIDE SEPARATION AND METHOD FOR PRODUCING SAME | Tosoh Corporation (JP) | 2025-12-17 | — | — | EP | claimed |
| CN-119425311-A | Purification method for efficiently removing degradation products of desthioamine liquid | 河北精致科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| WO-2024166977-A1 | AMINE COMPOSITION FOR CARBON DIOXIDE SEPARATION AND METHOD FOR PRODUCING SAME | 東ソー株式会社 | 2024-08-15 | — | — | WO | claimed |
| CN-114797469-B | Organic amine desulfurization and desorption accelerator and preparation method and application thereof | 双盾环境科技有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-115052637-B | Deodorant agent | 东曹株式会社 | 2024-03-01 | — | — | CN | claimed |
| US-20230356182-A1 | COMPOSITION FOR CARBON DIOXIDE SEPARATION AND METHOD FOR SEPARATING CARBON DIOXIDE | TOSOH CORPORATION (JP) | 2023-11-09 | — | — | US | claimed |
| CN-112316669-B | Organic amine desulfurizing agent and preparation method and application thereof | 合肥工业大学 | 2023-06-23 | — | — | CN | claimed |
| US-20230059218-A1 | DEODORANT | TOSOH CORPORATION (JP) | 2023-02-23 | — | — | US | claimed |
| CN-115646137-A | Organic amine desulfurizer capable of effectively reducing foaming problem | 北京北大先锋科技股份有限公司 | 2023-01-31 | — | — | CN | claimed |
| EP-1863475-A2 | NOVEL THIOPHENE DERIVATIVES AS SPHINGOSINE-1-PHOSPHATE-1 RECEPTOR AGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2007-12-12 | — | — | EP | claimed |
| EP-1863787-A1 | HYDOGRENATED BENZO[C]THIOPHENE DERIVATIVES AS IMMUNOMODULATORS | Actelion Pharmaceuticals Ltd. (CH) | 2007-12-12 | — | — | EP | claimed |
| EP-1863474-A1 | NOVEL THIOPHENE DERIVATIVES AS SPHINGOSINE-1-PHOSPHATE-1 RECEPTOR AGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2007-12-12 | — | — | EP | claimed |
| WO-2007046075-A1 | PIPERAZINE DERIVATIVES AS ANTIMALARIAL AGENTS | ACTELION PHARMACEUTICALS LTD (CH) | 2007-04-26 | — | — | WO | claimed |
| WO-2006137019-A1 | NOVEL THIOPHENE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2006-12-28 | — | — | WO | claimed |
| WO-2006100631-A1 | HYDROGENATED BENZO (C) THIOPHENE DERIVATIVES AS IMMUNOMODULATORS | ACTELION PHARMACEUTICALS LTD (CH) | 2006-09-28 | — | — | WO | claimed |
| WO-2006100633-A1 | NOVEL THIOPHENE DERIVATIVES AS SPHINGOSINE-l-PHOSPHATE-1 RECEPTOR AGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2006-09-28 | — | — | WO | claimed |
| WO-2006100635-A2 | NOVEL THIOPHENE DERIVATIVES AS SPHINGOSINE-1-PHOSPHATE-1 RECEPTOR AGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2006-09-28 | — | — | WO | claimed |
| WO-2002092578-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2002-11-21 | — | — | WO | claimed |
| WO-2002092577-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2002-11-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230059218-A1 | DEODORANT | DAO, DDO, DDAH1 | MAPT 2505/4885ATM 4216/4885SMN1; SMN2 2464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.